Less Focus on LDL in New CVD Prevention GuidelinesLomangino, KevinClinical Nutrition Insight: January 2014 - Volume 40 - Issue 1 - p 1–4 doi: 10.1097/01.NMD.0000442584.04932.0a Articles Abstract Author Information KEY MESSAGES For most patients, decisions regarding cholesterol-lowering drug therapy should be based on an overall cardiovascular risk score, not LDL cholesterol levels, according to new U.S. guidelines. Patients with a 10-year cardiovascular risk of 7.5% are now candidates for drug therapy—a threshold that will expand the population advised to consider statins. Patients at an increased risk of cardiovascular disease are advised to reduce saturated fat intake to 5% to 6% of energy, avoid red meat, and follow a risk-reducing dietary pattern. Mr. Lomangino is Editor, Clinical Nutrition Insight; E-mail: firstname.lastname@example.org. Mr. Lomangino has disclosed that he is a consultant to the Informed Medical Decisions Foundation and the American Association of Diabetes Educators. © 2014 by Lippincott Williams & Wilkins, Inc.